Total assets have shrunk to $2.8B from $4.7B in 2024Q1, with cash down to $55.6M, while goodwill of $1.8B (64% of assets) poses impairment risk that could erode the $2.5B equity.
GRAIL Inc. (GRAL) balance sheet — 8-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 |
|---|
| Total Current Assets | 914.72M | 953.85M | 819.86M | 156.06M | 295.63M | 242.73M | 595.92M | 557.51M | 649.23M |
| Cash & Short-Term Investments | 861.61M | 904.43M | 763.47M | 97.29M | 241.6M | 221.16M | 583.48M | 544.34M | 641.35M |
| Cash Only | 55.65M | 249.73M | 214.23M | 97.29M | 241.6M | 221.16M | 170.19M | 143.19M | 95.09M |
| Short-Term Investments | 805.96M | 654.7M | 549.24M | 0 | 0 | 0 | 413.29M | 401.15M | 546.26M |
| Accounts Receivable | 19.76M | 18.3M | 24.64M | 22.35M | 18.61M | 6.88M | 0 | 0 | 0 |
| Days Sales Outstanding | 41.27 | 45.37 | 71.61 | 87.63 | 122.31 | 171.91 | - | - | - |
| Inventory | 17.76M | 16.02M | 18.63M | 21.7M | 19.75M | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 34.56 | 27.87 | 33.4 | 41.96 | 41.92 | - | - | - | - |
| Other Current Assets | 0 | 15.11M | 0 | 0 | 0 | 6.89M | 0 | 0 | 0 |
| Total Non-Current Assets | 1.93B | 1.97B | 2.16B | 4.4B | 5.31B | 9.5B | 110.38M | 78.01M | 37.61M |
| Property, Plant & Equipment | 133.25M | 103.88M | 135.43M | 169.38M | 198.72M | 216.37M | 101.39M | 59.46M | 33.04M |
| Fixed Asset Turnover | 1.48x | 1.42x | 0.93x | 0.55x | 0.28x | 0.07x | - | - | - |
| Goodwill | 0 | 0 | 0 | 888.94M | 1.5B | 6.2B | 0 | 0 | 0 |
| Intangible Assets | 1.78B | 1.85B | 2.02B | 2.69B | 2.94B | 3.07B | 0 | 0 | 0 |
| Long-Term Investments | 0 | 6.97M | 0 | 4.22M | 4.53M | 0 | 2.05M | 15.16M | 1.63M |
| Other Non-Current Assets | 14.32M | 6.75M | 11.12M | 7.98M | 6.14M | 7.1M | 6.94M | 3.38M | 2.94M |
| Total Assets | 2.84B | 2.92B | 2.98B | 4.56B | 5.6B | 9.74B | 706.3M | 635.52M | 686.85M |
| Asset Turnover | 0.06x | 0.05x | 0.04x | 0.02x | 0.01x | 0.00x | - | - | - |
| Asset Growth % | -14.96% | -2.05% | -34.53% | -18.66% | -42.47% | 1278.73% | 11.14% | -7.47% | - |
| Total Current Liabilities | 83.54M | 79.67M | 76.92M | 163.61M | 134.94M | 97.89M | 83.97M | 44.93M | 74.16M |
| Accounts Payable | 7.24M | 2.08M | 4.84M | 19.67M | 17.48M | 17.65M | 24.51M | 6.09M | 12.75M |
| Days Payables Outstanding | 8.67 | 3.62 | 8.68 | 38.05 | 37.1 | 56.2 | - | - | - |
| Short-Term Debt | 0 | 11.71M | 0 | 14.81M | 13.34M | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 1.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.11M | 65.87M | 22.69M | 87.64M | 65.96M | 4.51M | 12.41M | 23K | 267K |
| Current Ratio | 10.95x | 11.97x | 10.66x | 0.95x | 2.19x | 2.48x | 7.10x | 12.41x | 8.75x |
| Quick Ratio | 10.74x | 11.77x | 10.42x | 0.82x | 2.04x | 2.48x | 7.10x | 12.41x | 8.75x |
| Cash Conversion Cycle | 67.16 | 69.62 | 96.33 | 91.54 | 127.14 | - | - | - | - |
| Total Non-Current Liabilities | 217.49M | 264.48M | 402.98M | 747.13M | 821M | 209.51M | 60.49M | 40.06M | 12.32M |
| Long-Term Debt | 0 | 43.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 168.33M | 43.15M | 54.88M | 69.6M | 82.67M | 96.75M | 57.54M | 36.64M | 800K |
| Deferred Tax Liabilities | 772.59M | 218.58M | 345.86M | 676.03M | 735.19M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3.17M | -40.4M | 2.24M | 1.5M | 3.13M | 112.76M | 2.95M | 3.42M | 11.52M |
| Total Liabilities | 301.03M | 344.15M | 479.9M | 910.74M | 955.94M | 307.4M | 144.46M | 84.99M | 86.47M |
| Total Debt | 91.31M | 98.01M | 68.14M | 84.41M | 96.01M | 110.56M | 62.99M | 42.04M | 2.52M |
| Net Debt | 35.66M | -151.72M | -146.09M | -12.88M | -145.59M | -110.6M | -107.21M | -101.15M | -92.57M |
| Debt / Equity | 0.04x | 0.04x | 0.03x | 0.02x | 0.02x | 0.01x | 0.11x | 0.08x | 0.00x |
| Debt / EBITDA | -0.21x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -0.08x | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - |
| Total Equity | 2.54B | 2.58B | 2.5B | 3.65B | 4.65B | 9.43B | 561.84M | 550.53M | 600.37M |
| Equity Growth % | 2.99% | 2.97% | -31.34% | -21.52% | -50.73% | 1578.52% | 2.05% | -8.3% | - |
| Book Value per Share | 58.98 | 70.14 | 78.47 | 117.42 | 149.62 | 303.69 | 4.54 | 4.47 | 5.26 |
| Total Shareholders' Equity | 2.54B | 2.58B | 2.5B | 3.65B | 4.65B | 9.43B | 561.84M | 550.53M | 600.37M |
| Common Stock | 45K | 40K | 34K | 11.42B | 10.96B | 10.34B | 151K | 138K | 129K |
| Retained Earnings | -10.42B | -10.21B | -9.8B | -7.78B | -6.31B | -911.54M | -1.62B | -1.31B | -1.06B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.84M | 2.65M | 1.45M | 1.07M | 894K | 315K | 3.6M | 2.46M | 128K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying GRAL stock.
As of 2025, GRAIL Inc. (GRAL) had total assets of $2.92B including $953.8M in current assets.
GRAIL Inc. (GRAL) carries total debt of $98.0M, offset by $904.4M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
GRAIL Inc. (GRAL) has total shareholders' equity (book value) of $2.58B ($70.14 book value per share). Book value represents the net worth of the company belonging to common stock holders.
GRAIL Inc. (GRAL) reported a current ratio of 11.97x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Reimbursement and cash burn
Metrics are mathematically derived from official filings.
Balance Sheet Shrinks as Cash Burns
Total assets declined from $4.7B in 2024Q1 to $2.8B in 2026Q2, per reported figures, as cash fell from $974.1M to $55.6M, indicating a rapid depletion of the post-spin-off cushion.
The balance sheet is contracting as the company consumes its cash reserves to fund operations and clinical trials. The decline in total assets is driven primarily by cash burn, with cash dropping from $974.1M in 2024Q1 to $55.6M in 2026Q2, a 94% reduction. This trajectory suggests that without additional capital raises or a path to profitability, the company's liquidity buffer is eroding, though the low debt levels provide some flexibility.
Minimal Leverage Masks Refinancing Risk
Debt-to-equity remains low at 0.04 in 2026Q2, per balance sheet data, with total debt of $91.3M, but the company's negative operating margins and cash burn suggest that any future borrowing could be costly.
The company's leverage is minimal, with a D/E ratio of 0.04 and total debt of $91.3M, which is modest relative to equity of $2.5B. However, the lack of significant debt may indicate limited access to credit markets given the company's negative profitability and cash burn. The low leverage provides a cushion, but investors should monitor whether the company can secure favorable financing terms if needed to extend its runway.
Goodwill Dominates Asset Base
Goodwill of $1.8B represents 64% of total assets in 2026Q2, per balance sheet data, while PPE is only $133.3M, indicating an asset-light model with significant intangible risk.
The asset mix is heavily weighted toward goodwill and intangibles, which totaled $1.8B in 2026Q2, down from $2.1B in 2024Q3, suggesting potential impairment charges. PPE is modest at $133.3M, reflecting a laboratory-based model with low capital intensity. The concentration in goodwill raises the risk of future write-downs if the company's market value or growth prospects deteriorate, which could further erode equity.
Accumulated Deficit Deepens
Retained earnings worsened to -$10.4B in 2026Q2, per balance sheet data, reflecting cumulative losses of over $2.4B since the spin-off, while equity remains positive at $2.5B due to the large goodwill balance.
The equity position is supported by the large goodwill balance, but the accumulated deficit of -$10.4B highlights the magnitude of losses incurred. The company has not repurchased shares or paid dividends, and stock-based compensation of $19.6M in 2026Q2, per cash flow data, adds to dilution. The equity quality is questionable as it relies on intangible assets that may be subject to impairment, and the ongoing losses suggest that equity could be at risk if impairments occur.
Liquidity Cushion Narrows Rapidly
Current ratio remains high at 10.95 in 2026Q2, per balance sheet data, but cash of $55.6M covers only a fraction of quarterly operating losses, which averaged -$80M in free cash flow.
The current ratio of 10.95 suggests strong short-term liquidity, but this is misleading as the company's cash balance of $55.6M is insufficient to cover even one quarter of operating losses, which were -$173.8M in 2026Q2. The company's cash runway appears limited to less than one quarter based on current burn rates, indicating an urgent need for additional capital or a significant reduction in spending. The high current ratio is driven by low current liabilities, not by ample cash.
Goodwill Impairment Could Erase Equity
Goodwill of $1.8B, per balance sheet data, is the largest asset and could be impaired if the company's market value falls, potentially wiping out a significant portion of the $2.5B equity.
The balance sheet's most non-obvious risk is the $1.8B goodwill balance, which represents 64% of total assets. If the company's market capitalization declines below its book value or if clinical or regulatory setbacks occur, an impairment charge could be triggered, reducing equity and potentially pushing the balance sheet into negative territory. Investors should monitor the company's market valuation relative to book value and any indicators of impairment, as this could have a material impact on the reported financial position.